These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34873418)

  • 21. Dual-Targeting of miR-124-3p and ABCC4 Promotes Sensitivity to Adriamycin in Breast Cancer Cells.
    Hu D; Li M; Su J; Miao K; Qiu X
    Genet Test Mol Biomarkers; 2019 Mar; 23(3):156-165. PubMed ID: 30807260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA FOXD2-AS1 functions as a tumor promoter in colorectal cancer by regulating EMT and Notch signaling pathway.
    Yang X; Duan B; Zhou X
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3586-3591. PubMed ID: 28925486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silencing of long non-coding RNA FOXD2-AS1 inhibits the progression of gallbladder cancer by mediating methylation of MLH1.
    Gao J; Dai C; Yu X; Yin XB; Liao WJ; Huang Y; Zhou F
    Gene Ther; 2021 Jun; 28(6):306-318. PubMed ID: 32917950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A1BG-AS1 promotes adriamycin resistance of breast cancer by recruiting IGF2BP2 to upregulate ABCB1 in an m6A-dependent manner.
    Wang J; Xu J; Zheng J
    Sci Rep; 2023 Nov; 13(1):20730. PubMed ID: 38007504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
    Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with Akt and E2F1.
    Su F; He W; Chen C; Liu M; Liu H; Xue F; Bi J; Xu D; Zhao Y; Huang J; Lin T; Jiang C
    Cell Death Dis; 2018 Feb; 9(2):233. PubMed ID: 29445134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
    Liu ZB; Wang JA; Lv RQ
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
    Huang Y; Ni R; Wang J; Liu Y
    Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA DDX11-AS1 promotes cell growth, migration and invasion through regulating epithelial-mesenchymal transition in breast cancer.
    Xi X; Yang F; Ding Z; Zhuang H; Yuan H
    Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):40-44. PubMed ID: 38678629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer.
    Ma D; Chen C; Wu J; Wang H; Wu D
    Breast Cancer; 2019 Jan; 26(1):74-83. PubMed ID: 29974352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Potentiates Cell Apoptosis and Drug Sensitivity to Taxanes and Adriamycin in Breast Cancer.
    Yu J; Jin T; Zhang T
    Med Sci Monit; 2020 Jul; 26():e922672. PubMed ID: 32623440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of LncRNA FAM83H-AS1 in hepatocellular carcinoma promotes cell proliferation, migration and invasion by Wnt/β-catenin pathway.
    Ma YK; Shen TH; Yang XY
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7855-7862. PubMed ID: 31599410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of FOXD2-AS1 enhances proliferation and impairs differentiation of glioma stem cells by activating the NOTCH pathway via TAF-1.
    Wang Y; Cheng Y; Yang Q; Kuang L; Liu G
    J Cell Mol Med; 2022 May; 26(9):2620-2632. PubMed ID: 35419917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long noncoding RNA FOXD2-AS1 promotes glioma malignancy and tumorigenesis via targeting miR-185-5p/CCND2 axis.
    Shen F; Chang H; Gao G; Zhang B; Li X; Jin B
    J Cell Biochem; 2019 Jun; 120(6):9324-9336. PubMed ID: 30520141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Linc00518 Contributes to Multidrug Resistance Through Regulating the MiR-199a/MRP1 Axis in Breast Cancer.
    Chang L; Hu Z; Zhou Z; Zhang H
    Cell Physiol Biochem; 2018; 48(1):16-28. PubMed ID: 30001527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of long non-coding RNA FOXD2-AS1 promotes progression and predicts poor prognosis in tongue squamous cell carcinoma.
    Zhou G; Huang Z; Meng Y; Jin T; Liang Y; Zhang B
    J Oral Pathol Med; 2020 Nov; 49(10):1011-1018. PubMed ID: 32531865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Down-regulation of lncRNA Linc00152 suppressed cell viability, invasion, migration, and epithelial to mesenchymal transition, and reversed chemo-resistance in breast cancer cells.
    Hu XL; Wang J; He W; Zhao P; Wu WQ
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3074-3084. PubMed ID: 29863253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
    Li C; Feng S; Chen L
    Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.
    Bai T; Liu Y; Li B
    IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion.
    Lou KX; Li ZH; Wang P; Liu Z; Chen Y; Wang XL; Cui HX
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1358-1365. PubMed ID: 29565494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.